ADVISORY/ Phase Forward to Drive International Discusssions Regarding the Impact of the Web in Electronic Data Capture.

Business/Technology Editors & Healthcare/Pharmaceutical Editors

ADVISORY...for Monday (January 28)

--(BW HealthWire)

Who:

Phase Forward Incorporated, the leading provider of clinical informatics solutions for accelerating global pharmaceutical development.

What:

Dr. Paul Bleicher, Chairman and Chief Scientific Officer at Phase Forward, to monitor a panel at the Strategic Resource Institute's "The Future of Outsourcing in Clinical Drug Development" conference, on Tuesday, January 29, 2002 at 8:05 a.m.

Dr. Bleicher and Adam Baumgart, Director of Clinical Services at Phase Forward Europe, to present at Vision in Business' "Understanding Electronic Data Capture (EDC)" conference on Thursday, January 31, 2002.

Phase Forward to exhibit its Clintrace(TM) premier safety reporting and tracking system at the Institute for International Research (IIR) "ADRs 2002" conference, January 28-29, 2002.

-- Strategic Resource Institute's "The Future of Outsourcing in Clinical Drug Development" Conference, January 28-29, 2002, Philadelphia, Pa.

The Future of Outsourcing in Clinical Drug Development conference will feature a variety of panels that address the issues and innovations in clinical outsourcing, timesaving strategies, cost containment solutions, and moving compounds faster through trials. Dr. Bleicher will lead a panel titled, "The Future of Web-based Systems: Where is it Going?" This discussion will focus on how wireless and mobile technologies, data warehousing and other innovative solutions continue to improve the clinical trials process.

-- Vision in Business' "Understanding Electronic Data Capture (EDC)" Conference, January 31, 2002, London

The one-day conference will enhance the methods and solutions for running, managing, and validating trials with EDC technologies. Paul Bleicher will present a session titled, "Ensuring Compliance in Off-line Electronic Systems: Clarification and Implementation of the FDA 21 CFR Part 11 Regulations" which will discuss methods for using these new guidelines and electronic records to successfully execute and improve clinical trials and a drugs time to market. In addition, colleague Adam Baumgart will host a session titled, "Recognizing Data Errors and Flags in Different Systems and Reacting Appropriately," and discuss tactics for maintaining credible data in clinical trials.

-- IIR "ADRs 2002", January 28-29, 2002, London

This conference will address improvements in pharmacovigilance, including the need for more effective systems for monitoring ADRs. Safety managers, medical directors, and medical affairs attendees will have the opportunity to experience firsthand the capabilities of Phase Forward's Clintrace software, the industry's leading solution for safety reporting and tracking. Those present at this year's conference will hear presentations highlighting the latest advancements in drug development, ePharmacovigilance and MedDRA.

About Phase Forward Incorporated

Phase Forward Incorporated is the end-to-end solution provider for accelerating global pharmaceutical development. Phase Forward's InForm(TM) software product uses Internet technologies to conduct and manage clinical trials efficiently and effectively. The InForm software product has been used in more than 170 clinical trials worldwide. Other applications include the Clintrial(TM) software product, the market-leading clinical database management system (CDMS) and the Clintrace(TM) software product, the industry's premier safety reporting and tracking system. Phase Forward's software and service solutions allow sponsors of clinical trials to eliminate the need to transcribe and process traditional paper data forms, to access global clinical trial data in real-time, and to begin data analysis almost immediately after the last patient has visited the clinic. Phase Forward believes that use of its software products by clinical trial sponsors has the potential to cut one to two years off the current seven to nine years it takes to bring new drugs to market, enabling them to increase their revenue potential. Phase Forward Incorporated, a privately held company, is headquartered in Waltham, Mass. Additional information about Phase Forward is available at http://www.phaseforward.com.

Phase Forward, InForm, Clintrial and Clintrace are trademarks or registered trademarks of Phase Forward Incorporated or its subsidiaries in the United States Patent and Trademark Office and other jurisdictions. All other trademarks may be the property of their respective owners.